HLA-C and neoplasm: A less efficiently surface antigen expression and a reduced expression of the major histocompatibility complex (MHC) in tumor cells, which can decrease immune detection and immune cell activation, contributes to the evolution a clone selection of low immunogenic tumor cells that escape immune system surveillance [11,14,38].